Clinical Trial Update: A Phase II Trial of Gemcitabine and Oxaliplatin for Triple Negative Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

A Phase II trial evaluating gemcitabine plus oxaliplatin for triple-negative metastatic breast cancer was terminated, with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Emory University | Conditions: Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2012-07-26